Heart septal defects refer to congenital conditions characterized by abnormal openings or holes in the walls (septa) that separate the chambers of the heart. These defects can occur in the atrial septum (atrial septal defect, ASD) or the ventricular septum (ventricular septal defect, VSD). These openings disrupt the normal flow of blood through the heart, leading to potential complications such as increased pressure in the lungs and strain on the heart. The severity of symptoms and the necessary interventions vary, with some cases requiring surgical correction. Early diagnosis and intervention are crucial in managing heart septal defects, enabling healthcare professionals to implement appropriate treatment strategies and provide optimal care for affected individuals. Advances in medical science and technology continue to enhance our understanding of these defects, leading to improved diagnostic techniques and more effective treatment options.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt